ClassID:

21025

A61K38/45 - page 5 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Transferases (2)

Recent Application in this class:
#1201
20100222418
2010-09-02

Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy

#1202
20100215634
2010-08-26

VISFATIN THERAPEUTIC AGENTS FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS

#1203
20100203076
2010-08-12

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#1204
20100202987
2010-08-12

PREPARATION FOR IMPROVING THE PROTECTION OF HUMAN CELLS, ESPECIALLY CELLS OF THE HUMAN SKIN, FROM THE HARMFUL INFLUENCES OF OXIDATIVE NOXAE AND UV RADIATION

#1205
20100184650
2010-07-22

Treating post-seizure patients

#1206
20100184637
2010-07-22

Pharmaceutical and/or cosmetic composition containing an active antioxydant principle and cell energy activator

#1207
20100183579
2010-07-22

MEMORY ENHANCING PROTEIN

#1208
20100178297
2010-07-15

Means and methods for the recruitment and identification of stem cells

#1209
20100178280
2010-07-15

USE OF SIRT7 FOR TREATING AGE-RELATED DISEASES

#1210
20100167987
2010-07-01

Methods and pharmaceutical compositions for healing wounds

#1211
20100166781
2010-07-01

HAT ACETYLATION PROMOTERS AND USES OF COMPOSITIONS THEREOF IN PROMOTING IMMUNOGENICITY

#1212
20100158887
2010-06-24

Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity

#1213
20100151572
2010-06-17

ANTI-TUMORAL COMPOSITIONS METHODS

#1214
20100151061
2010-06-17

METHODS OF USING BENFOTIAMINE AND PYRIDOXAMINE COMPOSITIONS

#1215
20100136171
2010-06-03

GOOD TASTING FOOD PRODUCT CONTAINING AN AGENT FOR REDUCING CARBOHYDRATE UPTAKE; AND COMPOSITIONS CONTAINING SUCH AN AGENT

#1216
20100136004
2010-06-03

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS

#1217
20100136001
2010-06-03

Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders

#1218
20100129332
2010-05-27

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS

#1219
20100119563
2010-05-13

Solid fibrinogen preparation

#1220
20100119514
2010-05-13

Antibodies Against Cancer

#1221
20100113567
2010-05-06

Recombinant VSV For The Treatment of Tumor Cells

#1222
20100113563
2010-05-06

Method for Treating Pain with a Calmodulin Inhibitor

#1223
20100104537
2010-04-29

Methods of treating Parkinson's disease using viral vectors

#1224
20100099622
2010-04-22

Wound healing

#1225
20100086610
2010-04-08

Vault and vault-like carrier molecules

#1226
20100080845
2010-04-01

Cosmetic Methods And Compositions For Repairing Human Skin

#1227
20100069503
2010-03-18

Inhibition of mitogen-activated protein kinases in cardiovascular disease

#1228
20100056446
2010-03-04

Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases

#1229
20100040594
2010-02-18

Formulations for nonsurgical exogenous crosslink therapy

#1230
20100040593
2010-02-18

FORMULATIONS FOR NONSURGICAL EXOGENOUS CROSSLINK THERAPY

#1231
20100028366
2010-02-04

SYNERGISTIC EFFECT BETWEEN A CYANOGENIC SYSTEM AND ANOTHER OXIDATIVE INDUCING SYSTEM FOR TREATING TUMORS

#1232
20100016413
2010-01-21

Pathotropic targeted gene delivery system for cancer and other disorders

#1233
20100003226
2010-01-07

Methods and Compositions for Treating Disease

#1234
20100003199
2010-01-07

Protein kinase C therapy for the treatment of acute lung injury

#1235
20090325871
2009-12-31

Role of the Mk2 Pathway in Wound Repair

#1236
20090324646
2009-12-31

Targeting the histone code as a bacterial strategy for selectively modulating gene expression

#1237
20090324575
2009-12-31

Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis

#1238
20090318351
2009-12-24

METHOD OF TREATING ACUTE ST-ELEVATION MYOCARDIAL INFARCTION WITH A DELTA PKC ANTAGONIST

#1239
20090312405
2009-12-17

Methods to predict and prevent resistance to taxoid compounds

#1240
20090304640
2009-12-10

Transfection of Collagen-Producing Cells

#1241
20090285833
2009-11-19

CLOSTRIDIUM BOTULINUM C3 EXOTRANSFERASE COMPOSITIONS AND METHODS FOR TREATING TUMOUR SPREADING

#1242
20090285791
2009-11-19

Regenerating and enhancing development of muscle tissue

#1243
20090280103
2009-11-12

REGULATION OF MUSCLE REPAIR

#1244
20090270328
2009-10-29

Methods of increasing cerebral blood flow

#1245
20090264347
2009-10-22

Use of Blood Coagulation Factor XIII for Treating Hemophilia A

#1246
20090263368
2009-10-22

Genetic variations associated with psychiatric disorders

#1247
20090246187
2009-10-01

PROCESS FOR CONCENTRATION OF A POLYPEPTIDE

#1248
20090238836
2009-09-24

Hip kinase for fertility control

#1249
20090227030
2009-09-10

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#1250
20090227000
2009-09-10

Chimeric adenoviruses for use in cancer treatment

#1251
20090226427
2009-09-10

NOVEL PHARMACEUTICAL COMPOSITIONS FOR MODULATING ANGIOGENESIS

#1252
20090220503
2009-09-03

METHOD FOR TREATING CANCERS WITH INCREASED RAS SIGNALING

#1253
20090214508
2009-08-27

VEGF-activated ligands

#1254
20090214425
2009-08-27

Tumor therapy with replication competent sindbis viral vectors

#1255
20090208924
2009-08-20

Generation of Replication Competent Viruses for Therapeutic Use

#1256
20090208478
2009-08-20

TRANSDUCIBLE POLYPEPTIDES FOR MODIFYING METABOLISM

#1257
20090203769
2009-08-13

Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling

#1258
20090192091
2009-07-30

Peptide inhibitors of protein kinase C

#1259
20090192074
2009-07-30

Methods and pharmaceutical compositions for healing wounds

#1260
20090191269
2009-07-30

Use of gelatin and a cross-linking agent for producing a cross-linking therapeutic composition

#1261
20090191194
2009-07-30

INHIBITION OF PROTEIN KINASE C ALPHA FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

#1262
20090191176
2009-07-30

Chondroitin sulfate synthesis promoter

#1263
20090186816
2009-07-23

Polypeptide targeting to mitochondria

#1264
20090175841
2009-07-09

Compounds for improving nutritional status, cognition and survival

#1265
20090170910
2009-07-02

Wound healing

#1266
20090170095
2009-07-02

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

#1267
20090163578
2009-06-25

NOVEL MODIFICATION OF IMMUNOMODULATORY PROTEIN

#1268
20090156466
2009-06-18

Characterization of a MEKK binding site and uses thereof

#1269
20090149375
2009-06-11

USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER

#1270
20090149331
2009-06-11

Methods and compositions for polypeptide engineering

#1271
20090143293
2009-06-04

Peptide inhibitors of protein kinase C gamma for pain management

#1272
20090142408
2009-06-04

Telomerase delivery by biodegradable Nanoparticle

#1273
20090142336
2009-06-04

METABOLIC REGULATORS AND USES THEREOF

#1274
20090142325
2009-06-04

COMPOSITIONS AND METHODS FOR TREATING TUMOUR SPREADING

#1275
20090137493
2009-05-28

Inhibition of tumor metastases using protein kinase C (PKC) inhibitors

#1276
20090136917
2009-05-28

Systems and methods for viral therapy

#1277
20090123472
2009-05-14

Detection of mutations in a gene associated with resistance to viral infection, OAS1

#1278
20090123470
2009-05-14

Antibodies Against Cancer

#1279
20090123462
2009-05-14

FGFR AGONISTS

#1280
20090123457
2009-05-14

Lumican proteoglycan in the diagnosis and treatment of atherosclerosis

#1281
20090123371
2009-05-14

Molecular signature of cancer

#1282
20090105127
2009-04-23

Methods for stabilizing corneal tissue

#1283
20090104154
2009-04-23

Composition and method for killing of tumours

#1284
20090098114
2009-04-16

Methods of promoting growth of muscle tissue using ALK7

#1285
20090081195
2009-03-26

Inhibitors of Ste20-like Kinase (SLK) and Methods of Modulating Cell Cycle Progression and Cell Motility

#1286
20090075897
2009-03-19

Peptides derived from the C2 domain of epsilon PKC

#1287
20090074743
2009-03-19

Inositol pyrophosphates determine exocytotic capacity

#1288
20090074733
2009-03-19

THYMIDYLATE KINASE MUTANTS AND USES THEREOF

#1289
20090068167
2009-03-12

Compositions for promoting wound healing and treating psoriasis

#1290
20090062209
2009-03-05

Methods of use of epsilon inhibitor compounds for the attenuation of pain

#1291
20090062208
2009-03-05

Methods for maintaining blood-brain barrier integrity in hypertensive subjects using a delta-PKC inhibitor

#1292
20090062178
2009-03-05

METHODS OF USE OF GAMMA INHIBITOR COMPOUNDS FOR THE ATTENUATION OF PAIN

#1293
20090053190
2009-02-26

Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions

#1294
20090048174
2009-02-19

Methods for inhibiting angiogenesis and tumor growth by inhibition of beta or delta protein kinase C

#1295
20090048159
2009-02-19

KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF A CALRETICULIN PROTEIN TO A CELLULAR MEMBRANE

#1296
20090047309
2009-02-19

COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN

#1297
20090041798
2009-02-12

sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis

#1298
20090041740
2009-02-12

CANCER TREATMENT BY METABOLIC MODULATIONS

#1299
20090036361
2009-02-05

Use of Blood Coagulation Factor XIII for Treating Hemophilia A

#1300
20090010952
2009-01-08

PHARMACEUTICAL COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT OR ERP57 TRANSLOCATION

#1301
20090010876
2009-01-08

VISFATIN AND USES THEREOF

#1302
20090005302
2009-01-01

METHOD, APPARATUS, AND COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER

#1303
20080313753
2008-12-18

Compositions and methods for improving heart function

#1304
20080299135
2008-12-04

METHODS AND COMPOSITIONS FOR NERVE REGENERATION

#1305
20080299104
2008-12-04

METHODS FOR DETECTING AGENTS INVOLVED IN NEURONAL APOPTOSIS AND COMPOSITIONS THEREOF

#1306
20080280816
2008-11-13

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS

#1307
20080279821
2008-11-13

ARYLPIPERIDINYL AND ARYLPYRROLIDINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS

#1308
20080274491
2008-11-06

Modulation of the integrin linked kinase signaling pathway to promote cardiac cell proliferation and self-renewal

#1309
20080274077
2008-11-06

Method for Treating Neurological Disorders

#1310
20080263689
2008-10-23

Methods for identifying modulators of protein kinase C-epsilon (PKC) and method of treatment of aberrant glucose metabolism associated therewith

#1311
20080261886
2008-10-23

Single-dose administration of Factor VIIa

#1312
20080260713
2008-10-23

Neukinase, a downstream protein of neuregulin

#1313
20080248553
2008-10-09

Production of Bioavailable Folic Acid

#1314
20080242608
2008-10-02

Methods and compositions for treating and preventing neurologic disorders

#1315
20080241125
2008-10-02

MUC1-IκB kinase complexes and their activities

#1316
20080241076
2008-10-02

Method and composition for increasing Erythropoietin

#1317
20080233099
2008-09-25

Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels

#1318
20080233098
2008-09-25

RHO Family Antagonists and Their Use to Block Inhibition of Neurite Outgrowth

#1319
20080233096
2008-09-25

Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels

#1320
20080227738
2008-09-18

Compositions and methods for cell dedifferentiation and tissue regeneration

#1321
20080219962
2008-09-11

Method to Enhance the Bone Formation Activity of Bmp by Runx2 Acetylation

#1322
20080213243
2008-09-04

Hemostatic materials and dressing

#1323
20080207878
2008-08-28

Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins

#1324
20080206284
2008-08-28

Agent for treating allergic or hypersensitivity condition

#1325
20080206219
2008-08-28

Novel Indications for Transforming Growth Factor-Beta Regulators

#1326
20080206210
2008-08-28

Treating immunodeficiencies by intrathymic injection of nucleotide sequences

#1327
20080206195
2008-08-28

Compositions and Methods for Treating Disorders Associated with Abnormal Phosphate Metabolism

#1328
20080200481
2008-08-21

Method of treatment of myocardial infarction

#1329
20080199426
2008-08-21

Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders

#1330
20080187956
2008-08-07

Aldehyde tags, uses thereof in site-specific protein modification

#1331
20080181955
2008-07-31

Natural dietary supplement and method for enhancing human libido

#1332
20080181878
2008-07-31

Degradation-resistant fibrinogen sealants

#1333
20080181869
2008-07-31

THERAPEUTICS TO FACILITATE CELL TRANSPLANTATION FOR LIVER DISEASE

#1334
20080176789
2008-07-24

Purification of Factor Xlll Polypeptides From Biological Materials

#1335
20080175832
2008-07-24

Materials and Methods for Prevention and Treatment of RNA Viral Diseases

#1336
20080167247
2008-07-10

Peptide inhibitors of protein kinase C

#1337
20080159988
2008-07-03

Materials and methods for treating or preventing oxalate-related disease

#1338
20080145351
2008-06-19

Memory influencing protein

#1339
20080125358
2008-05-29

Methods for Chk2 inhibitor patient selection

#1340
20080124322
2008-05-29

Activation and inhibition of the immune system

#1341
20080124311
2008-05-29

Oligoadenylate Synthetase (OAS)

#1342
20080124308
2008-05-29

Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins

#1343
20080112997
2008-05-15

Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo

#1344
20080108640
2008-05-08

Method of restoring the incretin effect

#1345
20080096900
2008-04-24

Methods for treating atherosclerosis

#1346
20080095835
2008-04-24

Methods for treating cancers and restenosis with P21

#1347
20080090843
2008-04-17

Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma

#1348
20080085271
2008-04-10

Method of treating cell-migration conditions or diseases

#1349
20080075740
2008-03-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#1350
20080075737
2008-03-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor

#1351
20080069809
2008-03-20

Compositions and methods for the diagnosis and treatment of cancer

#1352
20080064021
2008-03-13

Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity

#1353
20080058245
2008-03-06

Vectors for Recombinant Protein Expression in E. Coli

#1354
20080045460
2008-02-21

TREATMENT OF PROSTATE CANCER BY INHIBITING LYN-TYROSINE KINASE

#1355
20080044459
2008-02-21

Enzymatic debridement therapy for abnormal cell proliferation

#1356
20080038245
2008-02-14

Methods of modulating angiogenesis

#1357
20080020000
2008-01-24

Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading

#1358
20080015249
2008-01-17

CANCER TREATMENT COMPOSITIONS AND METHOD USING NATURAL PLANT ESSENTIAL OILS

#1359
20080003272
2008-01-03

Fibrin adhesive granulate and method for its preparation

#1360
20080003209
2008-01-03

Method for treatment of neurodegenerative diseases and the effects of aging

#1361
20080003200
2008-01-03

GRP78 targeting peptides and methods employing same

#1362
20070299012
2007-12-27

Method of preventing progression of hypertension-induced heart failure with PKC peptides

#1363
20070298999
2007-12-27

Method for treating pain with a calmodulin inhibitor

#1364
20070281885
2007-12-06

Macrocylic oximyl hepatitis C protease inhibitors

#1365
20070280920
2007-12-06

PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIII

#1366
20070275099
2007-11-29

MST1 modulation of apoptosis in cardiac tissue and modulators of MST1 for treatment and prevention of cardiac disease

#1367
20070265221
2007-11-15

Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure

#1368
20070264241
2007-11-15

Compounds for Enhanced Cancer Therapy

#1369
20070259379
2007-11-08

Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity

#1370
20070254357
2007-11-01

Gene therapy using replication competent targeted adenoviral vectors

#1371
20070253932
2007-11-01

RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE

#1372
20070231313
2007-10-04

Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid

#1373
20070225264
2007-09-27

Drug delivery means

#1374
20070218465
2007-09-20

Therapeutic Applications of Aminolevulinate Synthase

#1375
20070203087
2007-08-30

CHONDROITIN SULFATE SYNTHESIS PROMOTER

#1376
20070202143
2007-08-30

Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints

#1377
20070196351
2007-08-23

Method of treating a knee meniscus with a cross-linking reagent to increase resistance to tearing or rupturing

#1378
20070184118
2007-08-09

Compositions and methods for oxalate reduction

#1379
20070179091
2007-08-02

Hedgehog Kinases and Their Use in Modulating Hedgehog Signaling

#1380
20070178066
2007-08-02

PATHOTROPIC TARGETED GENE DELIVERY SYSTEM FOR CANCER AND OTHER DISORDERS

#1381
20070167361
2007-07-19

Use of factor XIII for stimulating the perfusion of ischemic tissue

#1382
20070160543
2007-07-12

Haemostatic sprays and compositions

#1383
20070154467
2007-07-05

Detection of mutations in a gene associated with resistance to viral infection, OAS1

#1384
20070149483
2007-06-28

Methods and compounds for modulating triglyceride and vldl secretion

#1385
20070142285
2007-06-21

Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain

#1386
20070128585
2007-06-07

(+)-TRANS-4-(1-AMINOETHYL)-1-(4-PYRIDYCARBAMOYL)-CYCLOHEXANE AND METHOD FOR PROMOTING NEURAL GROWTH IN THE CENTRAL NERVOUS SYSTEM AND IN A PATIENT AT A SITE OF NEURONAL LESION

#1387
20070128166
2007-06-07

Adenoviral vectors having a protein IX deletion

#1388
20070122384
2007-05-31

Method for treating inflammatory bowel disease

#1389
20070122377
2007-05-31

Compositions and methods of treatment

#1390
20070116687
2007-05-24

Method of modulating cellular transmigration and agents for use therein

#1391
20070110809
2007-05-17

Stabilised compositions

#1392
20070110756
2007-05-17

Method for modulating P53 activity via methylation

#1393
20070098828
2007-05-03

Methods and compositions for the prevention and regression of neovascularization

#1394
20070093513
2007-04-26

Agent for repairing corneal perception

#1395
20070077254
2007-04-05

Targeting the histone code as a bacterial strategy for selectively modulating gene expression

#1396
20070066526
2007-03-22

Method for reducing risk of and extent of injury due to stroke in hypertensive subjects

#1397
20070059287
2007-03-15

Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same

#1398
20070053893
2007-03-08

Method of reducing immunological tolerance to malignancy

#1399
20070031878
2007-02-08

Methods and compositions for polypeptide engineering

#1400
20070031381
2007-02-08

Recombinant adenoviral vector and method of use

#1401
20070021340
2007-01-25

Use of blood coagulation factor XIII for treating hemophilia A

#1402
20070015709
2007-01-18

Method for treating Hemophilia B

#1403
20070009486
2007-01-11

Adenoviral vectors having a protein IX deletion

#1404
20070009481
2007-01-11

Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis

#1405
20060292113
2006-12-28

PROPHYLACTIC AND THERAPEUTIC TREATMENT OF THE DUCTAL EPITHELIUM OF A MAMMARY GLAND FOR CANCER

#1406
20060258686
2006-11-16

Method of treatment of myocardial infarction

#1407
20060258562
2006-11-16

Methods and pharmaceutical compositions for healing wounds

#1408
20060257848
2006-11-16

Methods of preventing or treating cell migration mediated conditions or diseases

#1409
20060252672
2006-11-09

Protein N-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other N-gylosylation-increasing methods, and engineered hosts expressing products with increased N-glycosylation

#1410
20060247192
2006-11-02

Control of apoptosis

#1411
20060246505
2006-11-02

Modulation of the synthesis of insulin

#1412
20060246038
2006-11-02

Method of treating a disorder by suicide gene therapy

#1413
20060246032
2006-11-02

Chimeric IL-10

#1414
20060241067
2006-10-26

Methods For inhibiting angiogenesis, cell migration, cell adhesion, and cell survival

#1415
20060239990
2006-10-26

Protein Arginine N-Methyltransferase 2 (PRMT-2)

#1416
20060239988
2006-10-26

Neuronal regeneration and compound administration methods

#1417
20060239975
2006-10-26

Methods for treating cancers and restenosis with p21

#1418
20060239974
2006-10-26

Enhancing cell migration by increasing telomerase activity

#1419
20060233854
2006-10-19

Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same

#1420
20060228776
2006-10-12

PINK-1 promoter

#1421
20060228346
2006-10-12

Constitutively active phosphatidylinositol 3-kinase and uses thereof

#1422
20060223143
2006-10-05

Methods and compositions for polypeptide engineering

#1423
20060222637
2006-10-05

Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors

#1424
20060216273
2006-09-28

Gene therapy for colorectal cancer

#1425
20060210532
2006-09-21

Means and methods for the recruitment and identification of stem cells

#1426
20060205688
2006-09-14

Method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase

#1427
20060199766
2006-09-07

Pharmaceutical composition comprising a factor VIIa and a factor XIII

#1428
20060194724
2006-08-31

Methods and systems for nerve regeneration

#1429
20060177423
2006-08-10

Composition and method for killing of tumours

#1430
20060168667
2006-07-27

Minibrain homologous proteins involved in the regulation of energy homeostasis

#1431
20060166225
2006-07-27

Methods and compositions for polypeptide engineering

#1432
20060160761
2006-07-20

Regulation of vascular endothelium using BMX tyrosine kinase

#1433
20060160732
2006-07-20

Compositions and methods for inhibiting cell senescence and hyperproliferative disorders

#1434
20060148702
2006-07-06

Methods of increasing cerebral blood flow

#1435
20060148086
2006-07-06

Vault and vault-like carrier molecules

#1436
20060142193
2006-06-29

Selective inhibition of rock1 in cardiac therapy

#1437
20060142178
2006-06-29

Method of treating cancer

#1438
20060140910
2006-06-29

Recombinant adenoviral vectors and methods of use

#1439
20060134140
2006-06-22

Compositions and methods for treating tumor spreading

#1440
20060127895
2006-06-15

Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer

#1441
20060121509
2006-06-08

Generation of replication competent viruses for therapeutic use

#1442
20060121011
2006-06-08

Combination gene delivery vehicles

#1443
20060106196
2006-05-18

Antigenic peptides derived from telomerase

#1444
20060105327
2006-05-18

Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma

#1445
20060104970
2006-05-18

Biological glue based on thrombin-conjugated nanoparticles

#1446
20060104967
2006-05-18

Method of converting the state of proteins

#1447
20060104966
2006-05-18

Transglutaminase linkage of agents to tissue

#1448
20060104946
2006-05-18

Method for treating inflammatory bowel disease

#1449
20060084697
2006-04-20

Pi3k antagonists as radiosensitizers

#1450
20060084091
2006-04-20

Methods and compositions for polypeptide engineering

#1451
20060068468
2006-03-30

ActRII receptor polypeptides, methods and compositions

#1452
20060067927
2006-03-30

Methods and compositions related to the modulation of intercellular junctions

#1453
20060057620
2006-03-16

Treatment of HIV infection

#1454
20060051338
2006-03-09

Inhibition of mitogen-activated protein kinases in cardiovascular disease

#1455
20060045896
2006-03-02

Topical compositions comprising benfotiamine and pyridoxamine

#1456
20060040853
2006-02-23

Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras

#1457
20060039893
2006-02-23

Adenoviral vectors having a protein IX deletion

#1458
20060035850
2006-02-16

Pharmaceutical composition comprising a thymidine kinase polynucleotide

#1459
20060035825
2006-02-16

Alpha 5 beta 1 and its ability to regulate the cell survival pathway

#1460
20060034812
2006-02-16

Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect

#1461
20060034804
2006-02-16

Adenoviral vectors having a protein IX deletion

#1462
20060030522
2006-02-09

ALK7 and myostatin inhibitors and uses thereof

#1463
20060024284
2006-02-02

Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels

#1464
20060024273
2006-02-02

Target cell-specific adenoviral vectors containing E3 and methods of use thereof

#1465
20060019882
2006-01-26

Use of Yops as caspase inhibitor

#1466
20060014672
2006-01-19

Tumor specific oligosaccharide epitopes and use thereof

#1467
20060002914
2006-01-05

Methods and compositions for treating neuropathies

#1468
20050281797
2005-12-22

Lung volume reduction using glue compositions

#1469
20050281796
2005-12-22

Targeting damaged lung tissue

#1470
20050281780
2005-12-22

Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancer

#1471
20050271622
2005-12-08

Construct of tumor-selective recombinant adenovirus, method for preparing the same and use thereof

#1472
20050267023
2005-12-01

Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms

#1473
20050265973
2005-12-01

Chimeric adenoviruses for use in cancer treatment

#1474
20050250719
2005-11-10

Inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases

#1475
20050249718
2005-11-10

Compositions and methods for treating disorders associated with abnormal phosphate metabolism

#1476
20050244378
2005-11-03

Method for treating glaucoma

#1477
20050238666
2005-10-27

Methods of enhancing stem cell engraftment

#1478
20050232901
2005-10-20

Materials and methods for treating or preventing oxalate-related disease

#1479
20050215483
2005-09-29

Peptide inhibitors of protein kinase C

#1480
20050202559
2005-09-15

Cancer treatment by metabolic modulations

#1481
20050191294
2005-09-01

Compositions and methods of use of targeting peptides for diagnosis and therapy

#1482
20050180959
2005-08-18

Kinases involved in the regulation of energy homeostasis

#1483
20050180955
2005-08-18

Methods of treating parkinson's disease using viral vectors

#1484
20050175601
2005-08-11

Use of LIMK-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease

#1485
20050159338
2005-07-21

Method for inhibiting the formation of seromas using factor XIII

#1486
20050153878
2005-07-14

Method for screening FGFR-4 agonists

#1487
20050147970
2005-07-07

Breast cancer associated polypeptide

#1488
20050142116
2005-06-30

Prevention and treatment of mycoplasma-associated diseases

#1489
20050124645
2005-06-09

Methods and compositions for increasing CD4lymphocyte immune responsiveness

#1490
20050123603
2005-06-09

Natural menaquinone 7 compositions

#1491
20050123524
2005-06-09

Pharmaceutical compositions and methods for treating neuronal damages and neurodegenerative diseases

#1492
20050119159
2005-06-02

Remedy for ischemic heart failure

#1493
20050118253
2005-06-02

Systemic delivery of serum stable plasmid lipid particles for cancer therapy

#1494
20050112709
2005-05-26

Histone h3methyltransferase polypeptide

#1495
20050112113
2005-05-26

Presbyopia treatment by lens alteration

#1496
20050101677
2005-05-12

Presbyopia treatment by lens alteration

#1497
20050095231
2005-05-05

Modified adenovirus containing a fiber replacement protein

#1498
20050080026
2005-04-14

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

#1499
20050079158
2005-04-14

Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof

#1500
20050074830
2005-04-07

Detection of sphingosine kinase activity and sphingosine kinase agonist or antagonist activity